University of Colorado School of Medicine
Family Medicine
Dr. Oser is Associate Professor and Director of the High Plains Research Network in the Department of Family Medicine at the University of Colorado and Director of the Primary Care Diabetes Lab. Her research focuses on the use of diabetes technologies in primary care. She serves on the American Diabetes Association Youth Strategies National Committee and the Scientific and Medical Programs Oversight National Committee, as well as Treasurer of the Behavioral Research in Diabetes Group Exchange.

Presenter of 1 Presentation

DEVELOPMENT OF A NOVEL VIRTUAL CGM INITIATION SERVICE TO ENHANCE CGM UPTAKE IN PRIMARY CARE PRACTICES

Session Type
Virtual Oral Presentations Session
Date
Thu, 28.04.2022
Session Time
16:30 - 18:00
Room
Virtual Hall 1.1
Lecture Time
17:18 - 17:26

Abstract

Background and Aims

Primary Care (PC) performs diabetes management for approximately 50% of adult type 1 diabetes and 90% of type 2 diabetes in the United States, yet CGM uptake is significantly lower in PC than in endocrinology despite known glycemic and quality-of-life benefits. This project aims to increase CGM uptake in Colorado PC practices by developing a novel virtual CGM Initiation Service (virCIS) for PC practices.

Methods

vircis overview.jpg

The virCIS project partners with PC practices to identify candidates for CGM, perform CGM onboarding, and support transition of ongoing CGM management to the local PC practice. The program features a one-time, 45-minute CGM overview curriculum for practices, with instruction on how PC practices identify and enlist appropriate patients. virCIS will initiate CGM using a structured protocol implemented by clinical pharmacists, a diabetes care and education specialist, and a nutritionist, all with PC setting expertise. Program duration is three months, with routine updates to the referring practice, and concluding with a virtual “warm handoff” visit between virCIS, the PC practice, and the patient.

Results

Primary outcomes include change in HbA1c and changes in CGM glycemic metrics. Secondary outcomes include changes in BMI, diabetes distress, practice satisfaction, and patient satisfaction. Economic analysis will also be conducted, and a toolkit will be developed to empower other PC settings to develop their own CGM initiation services.

Conclusions

We anticipate that virCIS will increase PC practices’ abilities to initiate and maintain CGM use while also improving glycemia, patient satisfaction, and practice satisfaction.

Hide